[1] |
Bsirini C, Smoller BR. Histologic mimics of malignant melanoma[J]. Singapore Med J, 2018,59(11):602⁃607. doi: 10.11622/smedj.2018041.
|
[2] |
Scalvenzi M, Costa C, De Fata Salvatores G, et al. Clinical and dermoscopic features of Spitz naevus by sex, age and anatomical site: a study of 913 Spitz naevi[J]. Br J Dermatol, 2018,179(3):769⁃770. doi: 10.1111/bjd.16564.
|
[3] |
Moscarella E, Lallas A, Kyrgidis A, et al. Clinical and dermoscopic features of atypical Spitz tumors: a multicenter, retrospective, case⁃control study[J]. J Am Acad Dermatol, 2015,73(5):777⁃784. doi: 10.1016/j.jaad.2015.08.018.
|
[4] |
Carrera C, Scope A, Dusza SW, et al. Clinical and dermoscopic characterization of pediatric and adolescent melanomas: multicenter study of 52 cases[J]. J Am Acad Dermatol, 2018, 78(2):278⁃288. doi: 10.1016/j.jaad.2017.09.065.
|
[5] |
Hillen LM, Vandyck H, Leunissen D, et al. Integrative histopathological and immunophenotypical characterisation of the inflammatory microenvironment in spitzoid melanocytic neoplasms[J]. Histopathology, 2021,78(4):607⁃626. doi: 10.1111/his.14259.
|
[6] |
刘芳, 王江潮, 刘宇, 等. Spitz样肿瘤320例临床及组织病理分析[J]. 中华皮肤科杂志, 2021,54(1):33⁃41. doi: 10.35541/cjd.20200927.
|
[7] |
Oaxaca G, Billings SD, Ko JS. p16 Range of expression in dermal predominant benign epithelioid and spindled nevi and melanoma[J]. J Cutan Pathol, 2020,47(9):815⁃823. doi: 10.1111/cup.13721.
|
[8] |
DiSano K, Tschen JA, Cho⁃Vega JH. Intratumoral heterogeneity of chromosome 9 loss and CDKN2A (p16) protein expression in a morphologically challenging spitzoid melanoma[J]. Am J Dermatopathol, 2013,35(2):277⁃280. doi: 10.1097/DAD.0b013 e31826b187b.
|
[9] |
McNeal AS, Liu K, Nakhate V, et al. CDKN2B loss promotes progression from benign melanocytic nevus to melanoma[J]. Cancer Discov, 2015,5(10):1072⁃1085. doi: 10.1158/2159⁃8290. CD⁃15⁃0196.
|
[10] |
Ma SA, O′Day CP, Dentchev T, et al. Expression of p15 in a spectrum of spitzoid melanocytic neoplasms[J]. J Cutan Pathol, 2019,46(5):310⁃316. doi: 10.1111/cup.13424.
|
[11] |
Kapur P, Selim MA, Roy LC, et al. Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis[J]. Mod Pathol, 2005,18(2):197⁃204. doi: 10.1038/modpathol.3800 281.
|
[12] |
Torres⁃Cabala C, Li⁃Ning⁃Tapia E, Hwu WJ. Pathology⁃based biomarkers useful for clinical decisions in melanoma[J]. Arch Med Res, 2020,51(8):827⁃838. doi: 10.1016/j.arcmed.2020.09. 008.
|
[13] |
Vyas NS, Charifa A, Desman GT, et al. Observational study examining the diagnostic practice of Ki67 staining for melanocytic lesions[J]. Am J Dermatopathol, 2019,41(7):488⁃491. doi: 10.1097/DAD.0000000000001379.
|
[14] |
王艳青, 郭莹. Spitz痣的病理特点及诊断[J]. 中华皮肤科杂志, 2021,54(4):308⁃312. doi: 10.35541/cjd.20200841.
|
[15] |
Guanziroli E, Del Gobbo A, Coggi A, et al. Nestin expression in spitzoid lesions: an immunohistochemical characterization with clinical and dermoscopic correlations0[J]. Appl Immunohistochem Mol Morphol, 2019,27(6):430⁃435. doi: 10.1097/PAI.0000000000000653.
|
[16] |
Garola R, Singh V. Utility of p16⁃Ki⁃67⁃HMB45 score in sorting benign from malignant Spitz tumors[J]. Pathol Res Pract, 2019,215(10):152550. doi: 10.1016/j.prp.2019.152550.
|
[17] |
Wiedemeyer K, Guadagno A, Davey J, et al. Acral Spitz nevi: a clinicopathologic study of 50 cases with immunohistochemical analysis of P16 and P21 expression[J]. Am J Surg Pathol, 2018,42(6):821⁃827. doi: 10.1097/PAS.0000000000001051.
|
[18] |
Gerami P, Jewell SS, Morrison LE, et al. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma[J]. Am J Surg Pathol, 2009,33(8):1146⁃1156. doi: 10.1097/PAS.0b013e3181a1ef36.
|
[19] |
Gammon B, Beilfuss B, Guitart J, et al. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe[J]. Am J Surg Pathol, 2012,36(1):81⁃88. doi: 10.1097/PAS.0b013e31822d5ff8.
|
[20] |
Gerami P, Li G, Pouryazdanparast P, et al. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms[J]. Am J Surg Pathol, 2012,36(6):808⁃817. doi: 10.1097/PAS.0b013e31824b1efd.
|
[21] |
Gerami P, Scolyer RA, Xu X, et al. Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations[J]. Am J Surg Pathol, 2013,37(5):676⁃684. doi: 10.1097/PAS.0b013e3182753de6.
|
[22] |
Yazdan P, Cooper C, Sholl LM, et al. Comparative analysis of atypical Spitz tumors with heterozygous versus homozygous 9p21 deletions for clinical outcomes, histomorphology, BRAF mutation, and p16 expression[J]. Am J Surg Pathol, 2014,38(5):638⁃645. doi: 10.1097/PAS.0000000000000160.
|
[23] |
Shao L, Akkari Y, Cooley LD, et al. Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)[J/OL]. Genet Med, 2021[2021⁃06⁃28]. doi: 10.1038/s41436⁃021⁃01214⁃w. https://www.nature.com/articles/s41436⁃021⁃01214⁃w.
|
[24] |
Wiesner T, He J, Yelensky R, et al. Kinase fusions are frequent in Spitz tumours and spitzoid melanomas[J]. Nat Commun, 2014,5:3116. doi: 10.1038/ncomms4116.
|
[25] |
Quan VL, Zhang B, Zhang Y, et al. Integrating next⁃generation sequencing with morphology improves prognostic and biologic classification of Spitz neoplasms[J]. J Invest Dermatol, 2020,140(8):1599⁃1608. doi: 10.1016/j.jid.2019.12.031.
|
[26] |
de la Fouchardière A, Tee MK, Peternel S, et al. Fusion partners of NTRK3 affect subcellular localization of the fusion kinase and cytomorphology of melanocytes[J]. Mod Pathol, 2021,34(4):735⁃747. doi: 10.1038/s41379⁃020⁃00678⁃6.
|
[27] |
Houlier A, Pissaloux D, Masse I, et al. Melanocytic tumors with MAP3K8 fusions: report of 33 cases with morphological⁃genetic correlations[J]. Mod Pathol, 2020,33(5):846⁃857. doi: 10.1038/s41379⁃019⁃0384⁃8.
|
[28] |
Amin SM, Haugh AM, Lee CY, et al. A comparison of morphologic and molecular features of BRAF, ALK, and NTRK1 fusion spitzoid neoplasms[J]. Am J Surg Pathol, 2017,41(4):491⁃498. doi: 10.1097/PAS.0000000000000761.
|
[29] |
任静, 任敏, 孔蕴毅, 等. 间变性淋巴瘤激酶阳性的Spitz肿瘤临床病理学特征及预后[J]. 中华病理学杂志,2019,48(3): 215⁃219. doi: 10.3760/cma.j.issn.0529⁃5807.2019.03.009.
|
[30] |
Ritter A, Tronnier M, Vaske B, et al. Reevaluation of established and new criteria in differential diagnosis of Spitz nevus and melanoma[J]. Arch Dermatol Res, 2018,310(4):329⁃342. doi: 10.1007/s00403⁃018⁃1818⁃8.
|
[31] |
Cho⁃Vega JH. A diagnostic algorithm for atypical spitzoid tumors: guidelines for immunohistochemical and molecular assessment[J]. Mod Pathol, 2016,29(7):656⁃670. doi: 10.1038/modpathol.2016.70.
|